位置:首页 > 蛋白库 > CRBA2_HUMAN
CRBA2_HUMAN
ID   CRBA2_HUMAN             Reviewed;         197 AA.
AC   P53672; Q4ZFX0; Q9Y562;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   03-AUG-2022, entry version 162.
DE   RecName: Full=Beta-crystallin A2;
DE   AltName: Full=Beta-A2 crystallin;
GN   Name=CRYBA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Wistow G.;
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 109-142 AND 158-185.
RX   PubMed=7490092; DOI=10.1006/geno.1995.1186;
RA   Hulsebos T.J.M., Cerosaletti K.M., Fournier R.E.K., Sinke R.J., Rocchi M.,
RA   Marzella R., Jenkins N.A., Gilbert N.C., Copeland N.G.;
RT   "Identification of the human beta A2 crystallin gene (CRYBA2): localization
RT   of the gene on human chromosome 2 and of the homologous gene on mouse
RT   chromosome 1.";
RL   Genomics 28:543-548(1995).
RN   [7]
RP   INVOLVEMENT IN CTRCT42, AND VARIANT CTRCT42 MET-50.
RX   PubMed=23508780; DOI=10.1007/s00439-013-1289-0;
RA   Reis L.M., Tyler R.C., Muheisen S., Raggio V., Salviati L., Han D.P.,
RA   Costakos D., Yonath H., Hall S., Power P., Semina E.V.;
RT   "Whole exome sequencing in dominant cataract identifies a new causative
RT   factor, CRYBA2, and a variety of novel alleles in known genes.";
RL   Hum. Genet. 132:761-770(2013).
RN   [8]
RP   VARIANT SER-7.
RX   PubMed=24035193; DOI=10.1016/j.ajhg.2013.08.002;
RA   Koehler K., Malik M., Mahmood S., Giesselmann S., Beetz C., Hennings J.C.,
RA   Huebner A.K., Grahn A., Reunert J., Nurnberg G., Thiele H., Altmuller J.,
RA   Nurnberg P., Mumtaz R., Babovic-Vuksanovic D., Basel-Vanagaite L.,
RA   Borck G., Bramswig J., Muhlenberg R., Sarda P., Sikiric A.,
RA   Anyane-Yeboa K., Zeharia A., Ahmad A., Coubes C., Wada Y., Marquardt T.,
RA   Vanderschaeghe D., Van Schaftingen E., Kurth I., Huebner A., Hubner C.A.;
RT   "Mutations in GMPPA cause a glycosylation disorder characterized by
RT   intellectual disability and autonomic dysfunction.";
RL   Am. J. Hum. Genet. 93:727-734(2013).
CC   -!- FUNCTION: Crystallins are the dominant structural components of the
CC       vertebrate eye lens.
CC   -!- SUBUNIT: Homo/heterodimer, or complexes of higher-order. The structure
CC       of beta-crystallin oligomers seems to be stabilized through
CC       interactions between the N-terminal arms (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       P53672; Q9NYG5-2: ANAPC11; NbExp=3; IntAct=EBI-750444, EBI-12224467;
CC       P53672; Q03989: ARID5A; NbExp=3; IntAct=EBI-750444, EBI-948603;
CC       P53672; P54253: ATXN1; NbExp=7; IntAct=EBI-750444, EBI-930964;
CC       P53672; P46379-2: BAG6; NbExp=3; IntAct=EBI-750444, EBI-10988864;
CC       P53672; Q9NP55: BPIFA1; NbExp=3; IntAct=EBI-750444, EBI-953896;
CC       P53672; Q5SWW7: C10orf55; NbExp=3; IntAct=EBI-750444, EBI-12809220;
CC       P53672; Q6P5X5: C22orf39; NbExp=3; IntAct=EBI-750444, EBI-7317823;
CC       P53672; Q9GZU7: CTDSP1; NbExp=3; IntAct=EBI-750444, EBI-751587;
CC       P53672; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-750444, EBI-3867333;
CC       P53672; O75190-2: DNAJB6; NbExp=3; IntAct=EBI-750444, EBI-12593112;
CC       P53672; Q13643: FHL3; NbExp=3; IntAct=EBI-750444, EBI-741101;
CC       P53672; Q5TD97: FHL5; NbExp=3; IntAct=EBI-750444, EBI-750641;
CC       P53672; P21333-2: FLNA; NbExp=3; IntAct=EBI-750444, EBI-9641086;
CC       P53672; P42858: HTT; NbExp=3; IntAct=EBI-750444, EBI-466029;
CC       P53672; O14901: KLF11; NbExp=3; IntAct=EBI-750444, EBI-948266;
CC       P53672; Q8IUC1: KRTAP11-1; NbExp=3; IntAct=EBI-750444, EBI-1052037;
CC       P53672; Q3SY46: KRTAP13-3; NbExp=3; IntAct=EBI-750444, EBI-10241252;
CC       P53672; Q8IUC3: KRTAP7-1; NbExp=3; IntAct=EBI-750444, EBI-18394498;
CC       P53672; Q14847-2: LASP1; NbExp=4; IntAct=EBI-750444, EBI-9088686;
CC       P53672; Q8NI38: NFKBID; NbExp=3; IntAct=EBI-750444, EBI-10271199;
CC       P53672; Q8TDS5: OXER1; NbExp=3; IntAct=EBI-750444, EBI-12813389;
CC       P53672; Q92569: PIK3R3; NbExp=4; IntAct=EBI-750444, EBI-79893;
CC       P53672; Q9BVN2: RUSC1; NbExp=3; IntAct=EBI-750444, EBI-6257312;
CC       P53672; P00441: SOD1; NbExp=3; IntAct=EBI-750444, EBI-990792;
CC       P53672; Q12933: TRAF2; NbExp=3; IntAct=EBI-750444, EBI-355744;
CC       P53672; Q15645: TRIP13; NbExp=5; IntAct=EBI-750444, EBI-358993;
CC       P53672; Q9H9P5-5: UNKL; NbExp=3; IntAct=EBI-750444, EBI-12817837;
CC       P53672; Q08AM6: VAC14; NbExp=3; IntAct=EBI-750444, EBI-2107455;
CC   -!- DOMAIN: Has a two-domain beta-structure, folded into four very similar
CC       Greek key motifs.
CC   -!- DISEASE: Cataract 42 (CTRCT42) [MIM:115900]: An opacification of the
CC       crystalline lens of the eye that frequently results in visual
CC       impairment or blindness. Opacities vary in morphology, are often
CC       confined to a portion of the lens, and may be static or progressive. In
CC       general, the more posteriorly located and dense an opacity, the greater
CC       the impact on visual function. {ECO:0000269|PubMed:23508780}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the beta/gamma-crystallin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF166331; AAD45388.1; -; mRNA.
DR   EMBL; BT007447; AAP36115.1; -; mRNA.
DR   EMBL; AC097468; AAX88918.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70665.1; -; Genomic_DNA.
DR   EMBL; BC006285; AAH06285.1; -; mRNA.
DR   EMBL; X86395; CAA60147.1; -; Genomic_DNA.
DR   EMBL; X86396; CAA60148.1; -; Genomic_DNA.
DR   CCDS; CCDS2429.1; -.
DR   PIR; S55440; S55440.
DR   PIR; S55442; S55442.
DR   RefSeq; NP_476434.1; NM_057093.1.
DR   RefSeq; NP_476435.1; NM_057094.1.
DR   AlphaFoldDB; P53672; -.
DR   SMR; P53672; -.
DR   BioGRID; 107802; 25.
DR   IntAct; P53672; 32.
DR   MINT; P53672; -.
DR   STRING; 9606.ENSP00000295728; -.
DR   iPTMnet; P53672; -.
DR   PhosphoSitePlus; P53672; -.
DR   BioMuta; CRYBA2; -.
DR   DMDM; 12644311; -.
DR   MassIVE; P53672; -.
DR   PaxDb; P53672; -.
DR   PeptideAtlas; P53672; -.
DR   PRIDE; P53672; -.
DR   ProteomicsDB; 56605; -.
DR   Antibodypedia; 34295; 52 antibodies from 15 providers.
DR   DNASU; 1412; -.
DR   Ensembl; ENST00000295728.7; ENSP00000295728.2; ENSG00000163499.12.
DR   Ensembl; ENST00000392096.6; ENSP00000375946.2; ENSG00000163499.12.
DR   GeneID; 1412; -.
DR   KEGG; hsa:1412; -.
DR   MANE-Select; ENST00000295728.7; ENSP00000295728.2; NM_057093.2; NP_476434.1.
DR   UCSC; uc002vjj.2; human.
DR   CTD; 1412; -.
DR   DisGeNET; 1412; -.
DR   GeneCards; CRYBA2; -.
DR   HGNC; HGNC:2395; CRYBA2.
DR   HPA; ENSG00000163499; Tissue enhanced (pancreas, pituitary gland).
DR   MalaCards; CRYBA2; -.
DR   MIM; 115900; phenotype.
DR   MIM; 600836; gene.
DR   neXtProt; NX_P53672; -.
DR   OpenTargets; ENSG00000163499; -.
DR   Orphanet; 98988; Early-onset anterior polar cataract.
DR   Orphanet; 98991; Early-onset nuclear cataract.
DR   PharmGKB; PA26909; -.
DR   VEuPathDB; HostDB:ENSG00000163499; -.
DR   eggNOG; ENOG502QVIR; Eukaryota.
DR   GeneTree; ENSGT00940000160306; -.
DR   HOGENOM; CLU_081883_0_0_1; -.
DR   InParanoid; P53672; -.
DR   OMA; SDCANIA; -.
DR   OrthoDB; 1142622at2759; -.
DR   PhylomeDB; P53672; -.
DR   TreeFam; TF331401; -.
DR   PathwayCommons; P53672; -.
DR   SignaLink; P53672; -.
DR   BioGRID-ORCS; 1412; 15 hits in 1065 CRISPR screens.
DR   ChiTaRS; CRYBA2; human.
DR   GenomeRNAi; 1412; -.
DR   Pharos; P53672; Tdark.
DR   PRO; PR:P53672; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P53672; protein.
DR   Bgee; ENSG00000163499; Expressed in islet of Langerhans and 91 other tissues.
DR   ExpressionAtlas; P53672; baseline and differential.
DR   Genevisible; P53672; HS.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0005212; F:structural constituent of eye lens; IBA:GO_Central.
DR   GO; GO:0002088; P:lens development in camera-type eye; IBA:GO_Central.
DR   GO; GO:0007601; P:visual perception; IBA:GO_Central.
DR   InterPro; IPR001064; Beta/gamma_crystallin.
DR   InterPro; IPR011024; G_crystallin-like.
DR   Pfam; PF00030; Crystall; 2.
DR   PRINTS; PR01367; BGCRYSTALLIN.
DR   SMART; SM00247; XTALbg; 2.
DR   SUPFAM; SSF49695; SSF49695; 1.
DR   PROSITE; PS50915; CRYSTALLIN_BETA_GAMMA; 4.
PE   1: Evidence at protein level;
KW   Cataract; Disease variant; Eye lens protein; Reference proteome; Repeat.
FT   CHAIN           1..197
FT                   /note="Beta-crystallin A2"
FT                   /id="PRO_0000057539"
FT   DOMAIN          12..52
FT                   /note="Beta/gamma crystallin 'Greek key' 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          53..99
FT                   /note="Beta/gamma crystallin 'Greek key' 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          106..147
FT                   /note="Beta/gamma crystallin 'Greek key' 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          148..196
FT                   /note="Beta/gamma crystallin 'Greek key' 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   REGION          1..11
FT                   /note="N-terminal arm"
FT   REGION          100..105
FT                   /note="Connecting peptide"
FT   VARIANT         7
FT                   /note="P -> S (in dbSNP:rs141631259)"
FT                   /evidence="ECO:0000269|PubMed:24035193"
FT                   /id="VAR_070208"
FT   VARIANT         50
FT                   /note="V -> M (in CTRCT42)"
FT                   /evidence="ECO:0000269|PubMed:23508780"
FT                   /id="VAR_070029"
FT   CONFLICT        117
FT                   /note="Q -> L (in Ref. 6; CAA60147)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   197 AA;  22096 MW;  F9C8E7CD48EB16C7 CRC64;
     MSSAPAPGPA PASLTLWDEE DFQGRRCRLL SDCANVCERG GLPRVRSVKV ENGVWVAFEY
     PDFQGQQFIL EKGDYPRWSA WSGSSSHNSN QLLSFRPVLC ANHNDSRVTL FEGDNFQGCK
     FDLVDDYPSL PSMGWASKDV GSLKVSSGAW VAYQYPGYRG YQYVLERDRH SGEFCTYGEL
     GTQAHTGQLQ SIRRVQH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025